$UBQU Ubiquitech Reports 2018 Gross Annual Revenues of

New Post Public Reply Private Reply Replies (0) Message Board
hotforpenny
724
$UBQU
Ubiquitech Reports 2018 Gross Annual Revenues of $3,760,099Press Release | 03/04/2019

DENVER, CO, March 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Ubiquitech Software Corp. (OTC: UBQU), through its operating subsidiary HempLifeToday.com, today announced its fiscal year end 2018 financial results. Revenues for the year were $3,760,099, and the company had net income of $5,275 for the year ending November 30, 2018.

CEO, James Ballas, said: “We are extremely happy to report company results for the fiscal year end 2018. As CEO, I am well aware that results have leveled off over the last few quarters and this is due to the fact that the company continued to invest heavily in growth strategies while regulatory and industry conditions remained challenging. The company will continue to adjust and invest throughout the first half of the current fiscal year. The CannazALL brand recognition initiatives currently being developed will continue to solidify our foothold in the growing CBD marketplace, and we expect improved growth now that favorable legislation has been enacted. With our investment in the company we look forward to improving and expanding our customer support, increasing the speed in which customers receive products, improving our customer online experience, adding new CannazALL CBD products, increasing our advertising budgets and exploring new ad platforms, and announcing phase two of our extremely popular Ambassador Program. The entire staff at HempLife Today is working hard and we firmly believe that we are on the right track to achieve all of our stated goals for the company. Please bear with us as we continue to build the company and we will have lots of exciting news to come, including updates on our name and symbol change which we know you all are waiting for.”

About Ubiquitech Software Corp

Ubiquitech Software Corp. (UBQU) Stock Research Links

UBQU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hyzon Motors Plans Delisting from Nasdaq—What This Means

Updated Category News Views 195

Hyzon Motors Announces Delisting from Nasdaq Hyzon Motors Inc. is making a significant shift regarding its stock trading status. This U.S. company, known for its commitment to high-performance hydrogen fuel cell technology, has decided to inform Nasdaq Stock Market of its intent to delist its Class A common stock and publicly traded warrants. This move comes as part of...

Continue Reading
Unlock the Potential of Crypto Staking with Keynode.net

Updated Category News Views 113

Your Gateway to High Returns in Crypto Staking As the digital currency landscape continues to expand, platforms like Keynode.net are leading the charge in offering unprecedented opportunities for investors. For those seeking impressive annual percentage yields (APY) through crypto staking, Keynode.net has emerged as a premier choice. Its user-friendly interface, robust...

Continue Reading
Critical Updates for Rocket Pharmaceuticals Investors Amid Lawsuit

Updated Category News Views 263

Overview of the Class Action Lawsuit Against Rocket Pharmaceuticals Pomerantz LLP has initiated a class action lawsuit against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) highlighting various concerns regarding the company's business practices. Investors who have suffered losses during the stipulated Class Period should take note of this unfolding situation. Key Details...

Continue Reading
Revitalizing Economic Growth at the 23rd SMDO Conference

Updated Category News Views 141

Revitalizing Economic Growth at the 23rd SMDO Conference The 23rd Annual South Metro Development Outlook (SMDO25) Conference stands as a pivotal forum for industry leaders, policymakers, and community stakeholders. It is designed to foster collaboration and tackle some of the most pressing issues faced by the region today. Set against the backdrop of changing federal...

Continue Reading
SciBase's Strong Growth in Q1 2025: Key Highlights and Future

Updated Category News Views 222

Strong First Quarter Results for SciBase In the recent interim report, SciBase has showcased an impressive performance for the first quarter of 2025. The medical technology company, renowned for its innovative dermatological solutions, recorded net sales of TSEK 8,856, marking a remarkable increase of 46% from the previous year’s figures. Financial Performance Overview...

Continue Reading